Efficient co-delivery of immiscible hydrophilic/hydrophobic chemotherapeutics by lipid emulsions for improved treatment of cancer

Bo Zhang,1 Yunmei Song,2 Tianqi Wang,1 Shaomei Yang,1 Jing Zhang,1 Yongjun Liu,1 Na Zhang,1 Sanjay Garg2 1Department of Pharmaceutics, School of Pharmaceutical Sciences, Shandong University, Jinan, Shandong Province, People’s Republic of China; 2Centre for Pharmaceutical Innovation and De...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Zhang B, Song YM, Wang TQ, Yang SM, Zhang J, Liu YJ, Zhang N, Garg S
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2017
Materias:
Acceso en línea:https://doaj.org/article/ca0e99c1c2d841d080840d8f724f6371
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:ca0e99c1c2d841d080840d8f724f6371
record_format dspace
spelling oai:doaj.org-article:ca0e99c1c2d841d080840d8f724f63712021-12-02T04:23:13ZEfficient co-delivery of immiscible hydrophilic/hydrophobic chemotherapeutics by lipid emulsions for improved treatment of cancer1178-2013https://doaj.org/article/ca0e99c1c2d841d080840d8f724f63712017-04-01T00:00:00Zhttps://www.dovepress.com/efficient-co-delivery-of-immiscible-hydrophilichydrophobic-chemotherap-peer-reviewed-article-IJNhttps://doaj.org/toc/1178-2013Bo Zhang,1 Yunmei Song,2 Tianqi Wang,1 Shaomei Yang,1 Jing Zhang,1 Yongjun Liu,1 Na Zhang,1 Sanjay Garg2 1Department of Pharmaceutics, School of Pharmaceutical Sciences, Shandong University, Jinan, Shandong Province, People’s Republic of China; 2Centre for Pharmaceutical Innovation and Development (CPID), School of Pharmacy and Medical Sciences, University of South Australia, Adelaide, SA, Australia Abstract: Combinational nanomedicine is becoming a topic of much interest in cancer therapy, although its translation into the clinic remains extremely challenging. One of the main obstacles lies in the difficulty to efficiently co-deliver immiscible hydrophilic/hydrophobic drugs into tumor sites. The aim of this study was to develop co-loaded lipid emulsions (LEs) to co-deliver immiscible hydrophilic/hydrophobic drugs to improve cancer therapy and to explore the co-delivery abilities between co-loaded LEs and mixture formulation. Multiple oxaliplatin/irinotecan drug–phospholipid complexes (DPCs) were formulated. Co-loaded LEs were prepared using DPC technique to efficiently encapsulate both drugs. Co-loaded LEs exhibited uniform particle size distribution, desired stability and synchronous release profiles in both drugs. Co-loaded LEs demonstrated superior anti-tumor activity compared with the simple solution mixture and the mixture of single-loaded LEs. Furthermore, co-loaded nanocarriers could co-deliver both drugs into the same cells more efficiently and exhibited the optimized synergistic effect. These results indicate that co-loaded LEs could be a desired formulation for enhanced cancer therapy with potential application prospects. The comparison between co-loaded LEs and mixture formulation is significant for pharmaceutical designs aimed at co-delivery of multiple drugs. Keywords: cancer, combination therapy, co-delivery, lipid emulsions, drug–phospholipid complexZhang BSong YMWang TQYang SMZhang JLiu YJZhang NGarg SDove Medical Pressarticlecancercombination therapyco-deliverylipid emulsionsdrug-phospholipid complexMedicine (General)R5-920ENInternational Journal of Nanomedicine, Vol Volume 12, Pp 2871-2886 (2017)
institution DOAJ
collection DOAJ
language EN
topic cancer
combination therapy
co-delivery
lipid emulsions
drug-phospholipid complex
Medicine (General)
R5-920
spellingShingle cancer
combination therapy
co-delivery
lipid emulsions
drug-phospholipid complex
Medicine (General)
R5-920
Zhang B
Song YM
Wang TQ
Yang SM
Zhang J
Liu YJ
Zhang N
Garg S
Efficient co-delivery of immiscible hydrophilic/hydrophobic chemotherapeutics by lipid emulsions for improved treatment of cancer
description Bo Zhang,1 Yunmei Song,2 Tianqi Wang,1 Shaomei Yang,1 Jing Zhang,1 Yongjun Liu,1 Na Zhang,1 Sanjay Garg2 1Department of Pharmaceutics, School of Pharmaceutical Sciences, Shandong University, Jinan, Shandong Province, People’s Republic of China; 2Centre for Pharmaceutical Innovation and Development (CPID), School of Pharmacy and Medical Sciences, University of South Australia, Adelaide, SA, Australia Abstract: Combinational nanomedicine is becoming a topic of much interest in cancer therapy, although its translation into the clinic remains extremely challenging. One of the main obstacles lies in the difficulty to efficiently co-deliver immiscible hydrophilic/hydrophobic drugs into tumor sites. The aim of this study was to develop co-loaded lipid emulsions (LEs) to co-deliver immiscible hydrophilic/hydrophobic drugs to improve cancer therapy and to explore the co-delivery abilities between co-loaded LEs and mixture formulation. Multiple oxaliplatin/irinotecan drug–phospholipid complexes (DPCs) were formulated. Co-loaded LEs were prepared using DPC technique to efficiently encapsulate both drugs. Co-loaded LEs exhibited uniform particle size distribution, desired stability and synchronous release profiles in both drugs. Co-loaded LEs demonstrated superior anti-tumor activity compared with the simple solution mixture and the mixture of single-loaded LEs. Furthermore, co-loaded nanocarriers could co-deliver both drugs into the same cells more efficiently and exhibited the optimized synergistic effect. These results indicate that co-loaded LEs could be a desired formulation for enhanced cancer therapy with potential application prospects. The comparison between co-loaded LEs and mixture formulation is significant for pharmaceutical designs aimed at co-delivery of multiple drugs. Keywords: cancer, combination therapy, co-delivery, lipid emulsions, drug–phospholipid complex
format article
author Zhang B
Song YM
Wang TQ
Yang SM
Zhang J
Liu YJ
Zhang N
Garg S
author_facet Zhang B
Song YM
Wang TQ
Yang SM
Zhang J
Liu YJ
Zhang N
Garg S
author_sort Zhang B
title Efficient co-delivery of immiscible hydrophilic/hydrophobic chemotherapeutics by lipid emulsions for improved treatment of cancer
title_short Efficient co-delivery of immiscible hydrophilic/hydrophobic chemotherapeutics by lipid emulsions for improved treatment of cancer
title_full Efficient co-delivery of immiscible hydrophilic/hydrophobic chemotherapeutics by lipid emulsions for improved treatment of cancer
title_fullStr Efficient co-delivery of immiscible hydrophilic/hydrophobic chemotherapeutics by lipid emulsions for improved treatment of cancer
title_full_unstemmed Efficient co-delivery of immiscible hydrophilic/hydrophobic chemotherapeutics by lipid emulsions for improved treatment of cancer
title_sort efficient co-delivery of immiscible hydrophilic/hydrophobic chemotherapeutics by lipid emulsions for improved treatment of cancer
publisher Dove Medical Press
publishDate 2017
url https://doaj.org/article/ca0e99c1c2d841d080840d8f724f6371
work_keys_str_mv AT zhangb efficientcodeliveryofimmisciblehydrophilichydrophobicchemotherapeuticsbylipidemulsionsforimprovedtreatmentofcancer
AT songym efficientcodeliveryofimmisciblehydrophilichydrophobicchemotherapeuticsbylipidemulsionsforimprovedtreatmentofcancer
AT wangtq efficientcodeliveryofimmisciblehydrophilichydrophobicchemotherapeuticsbylipidemulsionsforimprovedtreatmentofcancer
AT yangsm efficientcodeliveryofimmisciblehydrophilichydrophobicchemotherapeuticsbylipidemulsionsforimprovedtreatmentofcancer
AT zhangj efficientcodeliveryofimmisciblehydrophilichydrophobicchemotherapeuticsbylipidemulsionsforimprovedtreatmentofcancer
AT liuyj efficientcodeliveryofimmisciblehydrophilichydrophobicchemotherapeuticsbylipidemulsionsforimprovedtreatmentofcancer
AT zhangn efficientcodeliveryofimmisciblehydrophilichydrophobicchemotherapeuticsbylipidemulsionsforimprovedtreatmentofcancer
AT gargs efficientcodeliveryofimmisciblehydrophilichydrophobicchemotherapeuticsbylipidemulsionsforimprovedtreatmentofcancer
_version_ 1718401273293701120